Cambridge Network Board

Our board is made up of Shareholders and Cambridge Network members elected by the serving Board of Directors.


Dr Andy Harter
Andy Harter headshot Andy Harter is an innovator and entrepreneur, responsible among other things for VNC software which allows remote control of one computer screen from another.  The technology is on over two billion devices, is on more different kinds of computer than any other application and is an official part of the internet. Before that, Andy was director of research and engineering at the influential AT&T Cambridge Laboratory and responsible for several ground-breaking technologies.  He has a PhD from the University of Cambridge where he is a Fellow of the Computer Laboratory and St Edmund’s College. He is a Trustee of both the Royal Academy of Engineering and the Institution of Engineering and Technology.

Shareholder Board Members

Amelia Armour, Amadeus Capital Partners

Amelia joined Amadeus Capital Partners in 2009 and is a Partner in the Early Stage Fund. Her current investment focus is on autonomous systems, AI and machine learning, cloud computing, digital health and medical technology.

She is a Director on the boards of Cambridge Touch Technologies, a company developing the next generation of ‘force touch’ for mobile phones and tablets; Paragraf who are manufacturing graphene and other two-dimensional materials for real-world applications; Immense Simulations an intelligent mobility enabling software company; Riverlane a developer of quantum software and SLAMcore, a spin-out from Imperial College, developing spatial intelligence for autonomous robotics and drones. Amelia is also an active board observer at other companies including AI decision making company Secondmind  and Graphcore, the developer of the Intelligence Processing Unit for next generation machine intelligence.

Amelia Armour photo

Marcus Johnson, Kirly Ltd

Marcus Johnson is the Senior Director in terms of years of service and his connections with the company go back to its foundation. At that time he was writing research on the gilt-edged market and one of his Edinburgh clients was a founding director of the company. Today he is actively engaged in all elements of the company’s activities. He is active in local business groups including as a Director of Cambridge Network (where Kirly Group Holdings is one of the original founding shareholders). 

Marcus Johnson, Kirly Group
Prof Andy Neely, University of Cambridge
Professor Andy Neely is Pro-Vice-Chancellor: Enterprise and Business Relations at the University of Cambridge, Head of the Institute for Manufacturing (IfM) and Head of the Manufacturing and Management Division of Cambridge University Engineering Department. He is a Fellow of Sidney Sussex College and Founding Director of the Cambridge Service Alliance. He is widely recognized for his work on the servitization of manufacturing, as well as his work on performance measurement and management. Previously he has held appointments at Cranfield University, London Business School, Cambridge University, where he was a Fellow of Churchill College, Nottingham University, where he completed his PhD and British Aerospace. He was Deputy Director of AIM Research – the UK’s management research initiative – from 2003 until 2012 and was elected a Fellow of the Academy of Social Science in 2008 and a Fellow of the Royal Academy of Engineering in 2018. He was awarded an OBE in the 2020 New Year’s Honours list.
Prof Andy Neely headshot
Dr. Peter Taylor, TTP
Peter is Managing Director of TTP Group. In 1987 he was one of the founders of TTP and subsequently built the science-based half of it. He is on the board of a number of external organisations involved in education, the arts, entrepreneurship, and promotion of high-tech industry. Peter has been responsible for product and technology developments in major markets including healthcare, communications and consumer products.
Peter Taylor headshot
Lee Welham, Deloitte
Lee Welham is a partner in the Deloitte Cambridge office with 14 years’ experience in serving a range of businesses in the FTSE, AIM and high growth private market sectors. Lee leads the Deloitte Equity Capital Markets group in Cambridge which provides a range of services to companies with an aspiration to IPO.  He has led and been involved in all major areas of capital markets work including acquisition due diligence; reporting accountant work and demerger projects.
Lee Welham headshot
Individual Board Members  
Dr. Andrew Lynn, Fluidic Analytics
Andrew Lynn is an entrepreneur and executive with a focus on life-science and physical-science ventures. Andrew founded Orthomimetics, a regenerative orthopaedic devices company, based on his PhD research conducted jointly at the University of Cambridge and the Massachusetts Institute of Technology. Dr Lynn subsequently led solid-state-lighting venture CamGaN Limited as CEO from the commencement of operations to the company’s acquisition in 2012. His efforts have earned him recognition in Europe as an inaugural winner of a Science|Business Academic Enterprise Award and in the US as a member of Technology Review Magazine’s TR35 list of the world’s top young innovators, leaders and entrepreneurs. He is CEO of Fluidic Analytics.
 Andrew Lynn headshot

Colin Manktelow, Brown Shipley
Colin is an Executive Director at Brown Shipley. After starting his career in banking, Colin joined a Cambridge-based stockbroking firm which subsequently became the nucleus of the Cambridge team in 1988. Colin looks after a wide range of private clients, charities and pension funds. He is a Chartered Fellow of the Chartered Institute for Securities & Investment and holds the Institute's Diploma.



Colin Manktelow headshot
Prof. Roderick Watkins, Anglia Ruskin University

Prof Watkins first joined Anglia Ruskin in 2014, as Pro Vice Chancellor and Dean of Arts, Law and Social Sciences, before being appointed Deputy Vice Chancellor (Research and Innovation) in 2015.  Prior to joining ARU, he was Dean of the Faculty of Arts and Humanities at Canterbury Christ Church University, where he was appointed Professor of Composition and Contemporary Music in 2005.

Caroline Rowland, ARM

Caroline Rowland joined Arm in September 2014 and is currently Vice President of Talent within the People Group, where she leads a talented global team of over 30 HR professionals against a diverse and progressive growth agenda. Talent covers a variety of areas at Arm including Leadership Development, Talent Management, People and Manager Development, Digital learning, Early careers & partners on Diversity, Equity and Inclusion. Caroline also leads the People Technology, Data & Analytics and People Operations team at Arm. With more than 20 years of experience Caroline has delivered in a variety of different HR roles beyond Arm at Diageo, the world’s largest drinks company, and Deloitte where she delivered in HR Business Partnering, Talent, Organizational Effectiveness & reward roles.

Caroline Rowland headshot
Claire Ruskin, Cambridge Network 
Claire has long been part of the Cambridge Phenomenon, starting in chip design as an electronics engineer at Cambridge Consultants and then delivering increasingly ambitious technical product developments for a range of clients around the world. She has extensive technical and practical knowledge and experience with developing products, people and companies. Claire travels worldwide, when needed, to talk about what makes Cambridge such a special place and how it has created so many technologies and companies. Claire is Executive Director of Cambridge Network.
Claire Ruskin headshot
Vicki Sanderson
With more than 20 years of experience in Human Resources at companies such as Domino Printing Sciences and Marshall of Cambridge, Vicki brings a vast amount of people management expertise and cultural knowledge. Vicki has achieved a BA in History and a CIPD.
Vicki Sanderson headshot
Dr Andy Williams, AstraZeneca
Andy Williams is Vice President – Cambridge Programme & Strategy for AstraZeneca. As well as delivery of the company’s strategy for its Cambridge footprint, Andy works with Cambridge and national stakeholders to develop the local infrastructure, promote the life sciences sector and inspire the next generation of scientists through AstraZeneca’s extensive local community outreach activities. With the arrival of AstraZeneca’s new strategic R&D centre at the Cambridge Biomedical Campus, Andy has been an active contributor to evolving Cambridge’s thinking in areas such as transport, skill development, amenities for the community and affordable housing.
Dr Andy Williams
Ken Woodberry, Microsoft Research
Ken is Deputy Managing Director at Microsoft's Cambridge Research Lab with responsibility for the lab's business-facing activities, including technology transfer, incubation, licensing, spin-outs, and other models for utilising the intellectual property generated by the lab's research groups. Woodberry joined Microsoft Research in September 2002 from RealVNC, a start-up he co-founded with colleagues from AT&T Laboratories in Cambridge.
Ken Woodberry headshot
David MardleGoodwin Procter (Company Secretary)

David Mardle is a partner in Goodwin’s Technology and Life Sciences group with 20 years of experience advising on financings and M&A transactions in the life sciences and technology sectors. Leveraging his significant M&A experience combined with his general corporate and capital markets expertise, David now concentrates his focus on representing emerging biotech companies providing counsel on corporate and capital markets transactions.  Prior to joining Goodwin in 2019, he was a partner at Taylor Wessing LLP.


David Mardle headshot